OR WAIT null SECS
August 01, 2019
A one-size-fits-all strategy is not the best approach for the development of a chemistry, manufacturing, and controls program.
July 16, 2019
An agreement with Sanofi gives Catalent access to commercial spray drying facility in Haverhill, UK.
July 02, 2019
Nanotechnology is enabling enhanced bioavailability, improved stability, and targeted delivery of challenging APIs.
June 19, 2019
New CDMO facility supports early-stage API manufacturing and scale up.
June 17, 2019
Two additional production lines expand Lonza’s HPAPI capacity at Visp, Switzerland facility.
Pfizer’s acquisition of Array BioPharma expands the company’s pipeline of investigational cancer therapies.
June 02, 2019
Excipients and new processing techniques can make a real difference in the development of highly potent therapies.
May 03, 2019
Automated candle and pressure-plate filtration equipment for removing catalyst residues from API slurries are operated in a closed system.
April 23, 2019
Cambrex’s expanded quality control laboratory supports generic API development.
April 02, 2019
Confidence in the quality systems and scientific competence of the API manufacturing team is essential.